Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gisli Jenkins

Showing results (101-110 of 208) with videos related to

Pageof 21
Sort By:
Science Signaling|November 5, 2016
Loss of epithelial Gq and G11 signaling inhibits TGFβ production but promotes IL-33-mediated macrophage polarization and emphysemaAlison E John, Michael R Wilson, Anthony Habgood, et al.
Thorax|June 10, 2022
Genome-wide association study across five cohorts identifies five novel loci associated with idiopathic pulmonary fibrosisRichard J Allen, Amy Stockwell, Justin M Oldham, et al.
ERJ Open Research|September 24, 2025
Ramadan fasting for patients with chronic respiratory diseases: a systematic review and consensus recommendations for healthcare professionalsFasihul Khan, Sameen Toor, Rayid Abdulqawi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 30, 2013
Preclinical SPECT/CT imaging of αvβ6 integrins for molecular stratification of idiopathic pulmonary fibrosisAlison E John, Jeni C Luckett, Amanda L Tatler, et al.
American Journal of Respiratory and Critical Care Medicine|November 23, 2020
Proportion of Idiopathic Pulmonary Fibrosis Risk Explained by Known Common Genetic Loci in European PopulationsOlivia C Leavy, Shwu-Fan Ma, Philip L Molyneaux, et al.
ERJ Open Research|June 18, 2019
Novel idiopathic pulmonary fibrosis susceptibility variants revealed by deep sequencingJose M Lorenzo-Salazar, Shwu-Fan Ma, Jonathan Jou, et al.
Respiratory Investigation|January 1, 2026
BAL cells analysis and lung function parameters in fibrotic hypersensitivity pneumonitis at baseline and in relation to survivalPunchalee Kaenmuang, Fiammetta Danzo, Simon Bax, et al.
BMJ Open Respiratory Research|December 30, 2023
Systemic corticosteroids in fibrotic lung disease: a systematic review and meta-analysisTyler Pitre, Leticia Kawano-Dourado, George V Kachkovski, et al.
BMJ Open Respiratory Research|January 20, 2026
Comprehensive characterisation of individuals with fibrotic interstitial lung disease: baseline insights from the INJUSTIS studyFasihul Khan, Iain Stewart, Lucy Howard, et al.
American Journal of Respiratory and Critical Care Medicine|February 14, 2024
Zinpentraxin Alfa for Idiopathic Pulmonary Fibrosis: The Randomized Phase III STARSCAPE TrialLuca Richeldi, Courtney Schiffman, Jürgen Behr, et al.
Pageof 21

Showing results (101-110 of 208) with videos related to

Sort By:
Pageof 21
Science Signaling|November 5, 2016
Loss of epithelial Gq and G11 signaling inhibits TGFβ production but promotes IL-33-mediated macrophage polarization and emphysemaAlison E John, Michael R Wilson, Anthony Habgood, et al.
Thorax|June 10, 2022
Genome-wide association study across five cohorts identifies five novel loci associated with idiopathic pulmonary fibrosisRichard J Allen, Amy Stockwell, Justin M Oldham, et al.
ERJ Open Research|September 24, 2025
Ramadan fasting for patients with chronic respiratory diseases: a systematic review and consensus recommendations for healthcare professionalsFasihul Khan, Sameen Toor, Rayid Abdulqawi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 30, 2013
Preclinical SPECT/CT imaging of αvβ6 integrins for molecular stratification of idiopathic pulmonary fibrosisAlison E John, Jeni C Luckett, Amanda L Tatler, et al.
American Journal of Respiratory and Critical Care Medicine|November 23, 2020
Proportion of Idiopathic Pulmonary Fibrosis Risk Explained by Known Common Genetic Loci in European PopulationsOlivia C Leavy, Shwu-Fan Ma, Philip L Molyneaux, et al.
ERJ Open Research|June 18, 2019
Novel idiopathic pulmonary fibrosis susceptibility variants revealed by deep sequencingJose M Lorenzo-Salazar, Shwu-Fan Ma, Jonathan Jou, et al.
Respiratory Investigation|January 1, 2026
BAL cells analysis and lung function parameters in fibrotic hypersensitivity pneumonitis at baseline and in relation to survivalPunchalee Kaenmuang, Fiammetta Danzo, Simon Bax, et al.
BMJ Open Respiratory Research|December 30, 2023
Systemic corticosteroids in fibrotic lung disease: a systematic review and meta-analysisTyler Pitre, Leticia Kawano-Dourado, George V Kachkovski, et al.
BMJ Open Respiratory Research|January 20, 2026
Comprehensive characterisation of individuals with fibrotic interstitial lung disease: baseline insights from the INJUSTIS studyFasihul Khan, Iain Stewart, Lucy Howard, et al.
American Journal of Respiratory and Critical Care Medicine|February 14, 2024
Zinpentraxin Alfa for Idiopathic Pulmonary Fibrosis: The Randomized Phase III STARSCAPE TrialLuca Richeldi, Courtney Schiffman, Jürgen Behr, et al.
Pageof 21